Atlas Venture Associates IX, LLC - Q4 2020 holdings

$631 Million is the total value of Atlas Venture Associates IX, LLC's 7 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 50.0% .

 Value Shares↓ Weighting
SKLZ NewSKILLZ INC$465,688,00023,284,403
+100.0%
73.80%
NTLA  INTELLIA THERAPEUTICS INC$87,873,000
+173.6%
1,615,3210.0%13.93%
-58.1%
SURF SellSURFACE ONCOLOGY INC$27,216,000
-15.1%
2,945,453
-36.6%
4.31%
-87.0%
SPRO  SPERO THERAPEUTICS INC$26,700,000
+73.7%
1,376,9680.0%4.23%
-73.4%
COGT NewCOGENT BIOSCIENCES INC$10,289,000916,196
+100.0%
1.63%
SNAP  SNAP INCcl a$7,519,000
+91.8%
150,1600.0%1.19%
-70.6%
SYBX  SYNLOGIC INC$5,728,000
+6.9%
2,651,9630.0%0.91%
-83.6%
UMRX ExitUNUM THERAPEUTICS INC$0-3,361,535
-100.0%
-8.14%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
INTELLIA THERAPEUTICS INC28Q3 2023100.0%
SNAP INC26Q3 202311.4%
SPERO THERAPEUTICS INC24Q3 202324.0%
SYNLOGIC INC24Q2 202335.6%
SURFACE ONCOLOGY INC21Q2 202333.3%
SKILLZ INC12Q3 202387.5%
UNUM THERAPEUTICS INC11Q3 202028.2%
COGENT BIOSCIENCES INC7Q2 20229.6%
CARBON BLACK INC6Q3 20197.8%
COHERUS BIOSCIENCES INC1Q3 202318.1%

View Atlas Venture Associates IX, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04
13F-HR2021-08-11

View Atlas Venture Associates IX, LLC's complete filings history.

Compare quarters

Export Atlas Venture Associates IX, LLC's holdings